Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome
about
Atypical hemolytic uremic syndromeHemolytic uremic syndrome: new developments in pathogenesis and treatmentRelative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotypeClinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in KoreaAdvances and challenges in the management of complement-mediated thrombotic microangiopathiesComplement System Part II: Role in ImmunityMutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohortHaemolytic uraemic syndrome.Analysis of rare variants in the C3 gene in patients with age-related macular degeneration.Excessive activation of the complement system in atypical hemolytic uremic syndrome: is it ready for prime time?Genetics and complement in atypical HUS.aHUS caused by complement dysregulation: new therapies on the horizon.Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?Thrombotic microangiopathy and associated renal disorders.STEC-HUS, atypical HUS and TTP are all diseases of complement activation.Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.Complement genes strongly predict recurrence and graft outcome in adult renal transplant recipients with atypical hemolytic and uremic syndrome.Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.Complement therapy in atypical haemolytic uraemic syndrome (aHUS).[Pathophysiology of atypical hemolytic uremic syndrome. Ten years of progress, from laboratory to patient].Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literatureA complicated case of atypical hemolytic uremic syndrome with frequent relapses under eculizumab.Rescue therapy with eculizumab in a transplant recipient with atypical haemolytic-uraemic syndrome.Acute Systolic Heart Failure Associated with Complement-Mediated Hemolytic Uremic SyndromeEarly eculizumab use in atypical haemolytic uraemic syndrome in a Jehovah's Witness refusing blood productsComplement involvement in kidney diseases: From physiopathology to therapeutical targetingRare genetic variants in the CFI gene are associated with advanced age-related macular degeneration and commonly result in reduced serum factor I levelsFHR3 Blocks C3d-Mediated Coactivation of Human B Cells.Mutations of complement factor I and potential mechanisms of neuroinflammation in acute hemorrhagic leukoencephalitis.The Genetics of Ultra-Rare Renal Disease.Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.The complement cascade and renal disease.Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration.Complement related kidney diseases: Recurrence after transplantation.New functional and structural insights from updated mutational databases for complement factor H, Factor I, membrane cofactor protein and C3.Routine use of clinical exome-based next-generation sequencing for evaluation of patients with thrombotic microangiopathies.Endothelial cells: source, barrier, and target of defensive mediators.The complement system in age-related macular degeneration: A review of rare genetic variants and implications for personalized treatment.Complementopathies.
P2860
Q21202864-AB636BA1-CF25-4C90-86EB-4FF8E2CC88C4Q24613517-AB7172AC-CB24-41E1-BF55-B344C5482F16Q24613907-E0371462-C66B-45FA-A420-7E4CC60A60B6Q26739894-EBA5E347-743D-47DA-80C8-B538FADDC496Q26796453-D4B02557-F576-4959-AB8D-61E52F4D207BQ28263460-16BD6E4C-3ADA-4391-BD89-F53C0DFE58ECQ28741729-726D671C-866C-43F2-998D-186FC80B6B88Q30244707-F3D8E34B-7D6B-4004-914A-0AD11756C46BQ30439919-D0591F3F-3603-4D6B-89E9-BAACBBE74AFBQ33388046-919A3DF6-6307-4D57-B3ED-C0EC27F618B4Q33389945-AA2D8E6B-0B4F-452A-B801-B8B648131AA3Q33390198-9320CF3F-60E4-4796-A841-0759448B1216Q33399052-1EED0F9D-5DBC-4646-9895-61C569D3A315Q33402372-A121F42D-D016-4F6C-B942-06D5135E7A89Q33403359-64316EF5-30A9-43E1-9C3B-559C022B16BCQ33403607-A07CDFE3-BCDE-49A5-BC5C-14EA8E1A55F5Q33405522-B91E8479-F5E4-4496-AE57-CF2E8FFC4EF6Q33406025-AB707EF8-E5E4-40A5-818A-8F192CFAB730Q33408733-8A189C45-29E5-4E18-96C9-3A5FEE47FB19Q33413660-51650CCF-F7C6-4BC1-BF6A-3AC1D5E479A3Q33414109-40AED37A-2152-4009-8DCE-B4654D2813CFQ33419812-BB4ABC60-CFBB-4073-9E76-846D9AC88F54Q33420998-2D950D86-B829-46AF-9879-3C525E940AFDQ33423593-9D3AEB3F-F631-4DEC-9D82-5431B1AC5DDDQ33427460-86B03898-9168-4C3C-955C-220B429B87BAQ33442901-498668FD-DEFE-4044-B013-698EA5FF616FQ35567841-A3C92A2D-7C27-42AB-BF37-AD4945E60A84Q35693886-09B23DD7-CB1B-41D2-B5DD-B276359A8390Q36045917-1D9841B1-361F-4DCB-ABB4-609D2D55E39CQ36518142-5AA58BC6-EF47-4525-A563-E062B424CDC3Q37032691-7551CE63-FAED-4C61-8464-39F3637D33A3Q37322141-FFE820DD-3804-47C4-93D0-0015D598B18FQ37502706-13D251CC-4BB4-47AD-83FD-8E00103F7F14Q37515621-3850FD1A-90B2-4204-A921-E9F7CEAB469DQ37522557-3212FEE4-8E87-4A0A-85F7-BC2A3B7FC141Q38304445-378432B9-4A4A-4410-8092-00A990633985Q38655720-776EEB8C-3AF1-4E7B-A134-209C8A20B6B6Q38991026-B9804E12-10EF-4204-9727-A35020CFD265Q39034874-D0BD400E-7D1B-44A5-8863-CEF24A06C6B0Q39142842-02761810-6EB7-4B7A-9EEF-FFC373C29686
P2860
Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mutations in components of com ...... ical hemolytic uremic syndrome
@ast
Mutations in components of com ...... ical hemolytic uremic syndrome
@en
Mutations in components of com ...... ical hemolytic uremic syndrome
@nl
type
label
Mutations in components of com ...... ical hemolytic uremic syndrome
@ast
Mutations in components of com ...... ical hemolytic uremic syndrome
@en
Mutations in components of com ...... ical hemolytic uremic syndrome
@nl
prefLabel
Mutations in components of com ...... ical hemolytic uremic syndrome
@ast
Mutations in components of com ...... ical hemolytic uremic syndrome
@en
Mutations in components of com ...... ical hemolytic uremic syndrome
@nl
P2093
P50
P3181
P356
P1433
P1476
Mutations in components of com ...... ical hemolytic uremic syndrome
@en
P2093
Jacques Blouin
Marie-Agnes Dragon-Durey
Mathieu Jablonski
Sara C Nilsson
Veronique Fremeaux-Bacchi
Wing H Kwan
P2888
P304
P3181
P356
10.1038/KI.2009.472
P407
P50
P577
2010-02-01T00:00:00Z
P5875
P6179
1053630731